Article: NPS Pharmaceuticals Announces Canadian Government $5.78 Million (U.S.) Funding for Allelix Biopharmaceuticals.

SALT LAKE CITY, Nov. 9 /PRNewswire/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP), today announced that the Canadian government has agreed to make an investment in NPS's proposed merger partner, Allelix Biopharmaceuticals Inc. through a program known as Technology Partnerships Canada. The $5.78 million (U.S.) investment will support the clinical research and development of ALX-0600, a potential new drug for the treatment of gastrointestinal disorders.

(Photo: http://www.newscom.com/cgi-bin/prnh/19990901/NPSLOGO )

In September, NPS and Allelix announced that they have agreed to a merger, which is expected to close in January 2000. The merged company will ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!